Compare TTI & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TTI | ENOV |
|---|---|---|
| Founded | 1981 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Fluid Controls |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 1996 | 2008 |
| Metric | TTI | ENOV |
|---|---|---|
| Price | $9.40 | $25.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $10.40 | ★ $47.38 |
| AVG Volume (30 Days) | ★ 1.5M | 1.3M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.70 | $6.36 |
| Revenue Next Year | $11.35 | $5.31 |
| P/E Ratio | $157.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.17 | $19.14 |
| 52 Week High | $12.54 | $34.28 |
| Indicator | TTI | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 41.91 | 59.70 |
| Support Level | $9.21 | $21.02 |
| Resistance Level | $10.86 | $27.11 |
| Average True Range (ATR) | 0.52 | 1.51 |
| MACD | -0.14 | 0.54 |
| Stochastic Oscillator | 19.11 | 90.35 |
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments, namely Completion Fluids & Products and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. The Water & Flowback Services Segment provides onshore oil and gas operators with comprehensive water management services. The majority of revenue is from the Completion Fluids & Products segment.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.